Erratum: Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation (Leukemia (2003) vol. 17 (2178-2182) 10.1038/sj.leu.2403138)

A. Venditti; L. Maurillo; F. Buccisano; G. Del Poeta; C. Mazzone; A. Tamburini; M. I. Del Principe; M. I. Consalvo; P. De Fabritiis; L. Cudillo; A. Picardi; A. Franchi; F. Lo-Coco; S. Amadori

doi:10.1038/sj.leu.2403278

Erratum: Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation (Leukemia (2003) vol. 17 (2178-2182) 10.1038/sj.leu.2403138)

A. Venditti, L. Maurillo, F. Buccisano, G. Del Poeta, C. Mazzone, A. Tamburini, M. I. Del Principe, M. I. Consalvo, P. De Fabritiis, L. Cudillo, A. Picardi, A. Franchi, F. Lo-Coco, S. Amadori

Fondazione Santa Lucia

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	373
Number of pages	1
Journal	Leukemia
Volume	18
Issue number	2
DOIs	https://doi.org/10.1038/sj.leu.2403278
Publication status	Published - Feb 2004

ASJC Scopus subject areas

Hematology
Cancer Research

Access to Document

10.1038/sj.leu.2403278

Cite this

Venditti, A., Maurillo, L., Buccisano, F., Del Poeta, G., Mazzone, C., Tamburini, A., Del Principe, M. I., Consalvo, M. I., De Fabritiis, P., Cudillo, L., Picardi, A., Franchi, A., Lo-Coco, F., & Amadori, S. (2004). Erratum: Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation (Leukemia (2003) vol. 17 (2178-2182) 10.1038/sj.leu.2403138). Leukemia, 18(2), 373. https://doi.org/10.1038/sj.leu.2403278

Erratum : Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation (Leukemia (2003) vol. 17 (2178-2182) 10.1038/sj.leu.2403138). / Venditti, A.; Maurillo, L.; Buccisano, F.; Del Poeta, G.; Mazzone, C.; Tamburini, A.; Del Principe, M. I.; Consalvo, M. I.; De Fabritiis, P.; Cudillo, L.; Picardi, A.; Franchi, A.; Lo-Coco, F.; Amadori, S.

In: Leukemia, Vol. 18, No. 2, 02.2004, p. 373.

Research output: Contribution to journal › Article › peer-review

Venditti, A, Maurillo, L, Buccisano, F, Del Poeta, G, Mazzone, C, Tamburini, A, Del Principe, MI, Consalvo, MI, De Fabritiis, P, Cudillo, L, Picardi, A, Franchi, A, Lo-Coco, F & Amadori, S 2004, 'Erratum: Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation (Leukemia (2003) vol. 17 (2178-2182) 10.1038/sj.leu.2403138)', Leukemia, vol. 18, no. 2, pp. 373. https://doi.org/10.1038/sj.leu.2403278

Venditti A, Maurillo L, Buccisano F, Del Poeta G, Mazzone C, Tamburini A et al. Erratum: Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation (Leukemia (2003) vol. 17 (2178-2182) 10.1038/sj.leu.2403138). Leukemia. 2004 Feb;18(2):373. https://doi.org/10.1038/sj.leu.2403278

Venditti, A. ; Maurillo, L. ; Buccisano, F. ; Del Poeta, G. ; Mazzone, C. ; Tamburini, A. ; Del Principe, M. I. ; Consalvo, M. I. ; De Fabritiis, P. ; Cudillo, L. ; Picardi, A. ; Franchi, A. ; Lo-Coco, F. ; Amadori, S. / Erratum : Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation (Leukemia (2003) vol. 17 (2178-2182) 10.1038/sj.leu.2403138). In: Leukemia. 2004 ; Vol. 18, No. 2. pp. 373.

@article{6286226b8c72405eb9137c0d01db2250,

title = "Erratum: Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation (Leukemia (2003) vol. 17 (2178-2182) 10.1038/sj.leu.2403138)",

author = "A. Venditti and L. Maurillo and F. Buccisano and {Del Poeta}, G. and C. Mazzone and A. Tamburini and {Del Principe}, {M. I.} and Consalvo, {M. I.} and {De Fabritiis}, P. and L. Cudillo and A. Picardi and A. Franchi and F. Lo-Coco and S. Amadori",

year = "2004",

month = feb,

doi = "10.1038/sj.leu.2403278",

language = "English",

volume = "18",

pages = "373",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Erratum

T2 - Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation (Leukemia (2003) vol. 17 (2178-2182) 10.1038/sj.leu.2403138)

AU - Venditti, A.

AU - Maurillo, L.

AU - Buccisano, F.

AU - Del Poeta, G.

AU - Mazzone, C.

AU - Tamburini, A.

AU - Del Principe, M. I.

AU - Consalvo, M. I.

AU - De Fabritiis, P.

AU - Cudillo, L.

AU - Picardi, A.

AU - Franchi, A.

AU - Lo-Coco, F.

AU - Amadori, S.

PY - 2004/2

Y1 - 2004/2

UR - http://www.scopus.com/inward/record.url?scp=10744222896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744222896&partnerID=8YFLogxK

U2 - 10.1038/sj.leu.2403278

DO - 10.1038/sj.leu.2403278

M3 - Article

AN - SCOPUS:10744222896

VL - 18

SP - 373

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 2

ER -